Supriya Lifescience said its General Manager - Sales and Marketing has been placed under judicial custody until July 17, 2026, following a Customs Department investigation under the NDPS Act. The company said the matter relates to a single export transaction and is currently before a competent court, adding that it expects no material operational or financial impact.